Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2025
Understanding Glycemia in the Post Discharge Period Through Blinded Continuous Glucose Monitoring.
СтатьяНаблюдательное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Patel Rahul, O'Connor Mollie Y, Sabean Amy, Ashley Annabelle, Zheng Hui, Yan Joyce, Steiner Barbara A, Anandakugan Nillani, Calverley Melissa, Bartholomew Rachel, Greaux Evelyn, Larkin Mary, Russell Steven J, Putman Melissa S, Flint Kristen L
Аннотация
OBJECTIVE: Transitions of care at hospital discharge are critical time periods for people with diabetes, but little is known about glycemia in the immediate postdischarge period.
METHODS: In this observational study, participants wore blinded Dexcom G6 Pro CGM during hospital admission on nonintensive care floors and then continued wearing blinded continuous glucose monitoring (CGM) for up to 10 days posthospital discharge. Clinical data were extracted from the electronic medical record. Percent time in range 70-180 mg/dl (TIR), above range, and below range from the inpatient and postdischarge periods were calculated. The percentage of participants achieving TIR ≥50% and ≥70%, incidence of hypoglycemia after discharge, change in inpatient and postdischarge CGM metrics, and predictors of postdischarge glycemia were determined.
RESULTS: A total of 24 adults (mean age 65.7 ± 13.6 years, 37.5% female) wore CGM after discharge with mean TIR 43.9 ± 33.2%, mean time above range 55.9 ± 33.3%, and median time below range 0% (0, 0.04). Of these participants, 41.7% had TIR ≥50%, and 29.2% had TIR ≥70%. Glycemia predischarge and postdischarge was similar (postdischarge vs inpatient TIR -3.7 ± 22.5%, P = .4). Of the clinical factors assessed, only inpatient glycemia was associated with achieving postdischarge glycemic targets. CGM detected 13 episodes of hypoglycemia occurring in 6 participants (25%) postdischarge.
CONCLUSIONS: Glycemia during the postdischarge period is suboptimal and glucose levels in the hospital may be an important predictor of glycemia after hospitalization. CGM may be useful in identifying hypoglycemia after discharge. Further studies are needed to understand the utility of CGM after hospital discharge.
METHODS: In this observational study, participants wore blinded Dexcom G6 Pro CGM during hospital admission on nonintensive care floors and then continued wearing blinded continuous glucose monitoring (CGM) for up to 10 days posthospital discharge. Clinical data were extracted from the electronic medical record. Percent time in range 70-180 mg/dl (TIR), above range, and below range from the inpatient and postdischarge periods were calculated. The percentage of participants achieving TIR ≥50% and ≥70%, incidence of hypoglycemia after discharge, change in inpatient and postdischarge CGM metrics, and predictors of postdischarge glycemia were determined.
RESULTS: A total of 24 adults (mean age 65.7 ± 13.6 years, 37.5% female) wore CGM after discharge with mean TIR 43.9 ± 33.2%, mean time above range 55.9 ± 33.3%, and median time below range 0% (0, 0.04). Of these participants, 41.7% had TIR ≥50%, and 29.2% had TIR ≥70%. Glycemia predischarge and postdischarge was similar (postdischarge vs inpatient TIR -3.7 ± 22.5%, P = .4). Of the clinical factors assessed, only inpatient glycemia was associated with achieving postdischarge glycemic targets. CGM detected 13 episodes of hypoglycemia occurring in 6 participants (25%) postdischarge.
CONCLUSIONS: Glycemia during the postdischarge period is suboptimal and glucose levels in the hospital may be an important predictor of glycemia after hospitalization. CGM may be useful in identifying hypoglycemia after discharge. Further studies are needed to understand the utility of CGM after hospital discharge.